COVID-19 and Tuberculosis Coinfection: A Report of Two Cases
Abstract
COVID-19 and its sequelae are primarily known to affect the respiratory system. However, it can have varied manifestations affecting other systems as well. COVID-19 can lead to reactivation of tuberculosis which
can have unusual extrapulmonary presentations as well. Coinfection of COVID-19 and tuberculosis is a risk factor for poor outcome. Here, we describe a series of two cases of COVID-19 with tuberculosis. In the first case, a patient who had apparently recovered from COVID-19 presented only a week later with polyserositis, and ultimately was diagnosed to be a case of disseminated tuberculosis. In the second case, the patient presented with COVID-19 and TB together. Clinicians must be aware and vigilant for this coinfection and complication in COVID-19 recovered patients even if they were of mild/ asymptomatic category.
How to cite this article:
Daga MK, Kumar N, Mawari G, Chand S, Aarthi J, Raghu RV, Sachdeva K. COVID-19 and Tuberculosis
Coinfection: A Report of Two Cases. Int J Preven Curat Comm Med. 2021;7(1):20-24.
DOI: https://doi.org/10.24321/2454.325X.202103
References
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F,
Carson G, Merson L, Lee J, Plotkin D, Sigfrid L, Halpin S, Jackson C, Gamble C, Horby PW, Nguyen-Van-Tam JS,
Ho A, Russell CD, Dunning J, Openshaw PJ, Baillie JK, Semple MG, ISARIC4C Investigators. Features of 20 133
UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective
observational cohort study. BMJ. 2020;369:m1985. [PubMed] [Google Scholar]
Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and
meta-analysis. J Infect. 2020;81(2):266-75. [PubMed] [Google Scholar]
Tadolini M, Codecasa LR, GarcÃa-GarcÃa JM, Blanc FX, Borisov S, Alffenaar JW, Andrejak C, Bachez P, Bart PA,
Belilovski E, Landivar JC, Centis R, D’Ambrosio L, Souza-Galvao MLD, Dominguez-Castalleno A, Dourmane S,
Jachym MF, Froissart A, Giacomet V, Goletti D, Grard S, Gualano G, Izadifar A, Du DL, Royo MM, Mazza-Stalder
J, Motta I, Ong CWM, Palmieri F, Riviere F, Rodrigo T, Silva DR, Sanchez-Montalva A, Saporiti M, Scarpellini P,
Schlemmer F, Spanevello A, Sumarokova E, Tabernero E, Tambyah PA, Tiberi S, Torre A, Visca D, Murguiondo
MZ, Sotgiu G, Migliori GB. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur
Respir J. 2020;56(1):2001398. [PubMed] [Google Scholar]
Motta I, Centis R, D’Ambrosio L, Garcia-Garcia JM, Goletti D, Gualano G, Lipani F, Palmieri F, Sanchez-Montalva A, Pontali E, Sotgiu G, Spanevello A, Stochino C, Tabernero E, Tadolini M, van den Boom M, Villa S, Visca D, Migliori
GB. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two
cohorts. Pulmonology. 2020;26(4):233-40. [PubMed] [Google Scholar]
Kumar R, Bhattacharya B, Meena V, Soneja M, Wig N. COVID-19 and TB co-infection - ‘Finishing touch’’
in perfect recipe to ‘severity’ or ‘death’. J Infect. 2020;81(3):e39-e40. [Google Scholar]
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X,
Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Feb;395(10223):497-
[Google Scholar]
Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung TWH, Tam AR, Yip CCY, Leung
KH, Fung AYF, Zhang RR, Lin Y, Cheng HM, Zhang AJX, To KKW, Chan KH, Yuen KY, Leung WK. Gastrointestinal
Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic
Review and Meta-analysis. Gastroenterology. 2020 Jul;159(1):81-95. [PubMed] [Google Scholar]
Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic
Review of Imaging Findings in 919 Patients. Am J Roentgenol. 2020 Jul;215(1):87-93. [PubMed] [Google
Scholar]
Pathak L, Gayan S, Pal B, Talukdar J, Bhuyan S, Sandhya S. Coronavirus activates a stem cell-mediated
defense mechanism that accelerates activation of dormant tuberculosis: implications for the COVID-19
pandemic. bioRxiv. 2020 May 6.
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control
and Prevention. JAMA. 2020 Apr 7;323(13):1239-42. [PubMed] [Google Scholar]
Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. PersistentSymptoms in Patients After Acute COVID-19. JAMA. 2020 Aug 11;324(6):603-5. [PubMed] [Google Scholar]
Pai M, Daftary A, Satyanarayana S. TB control: challenges and opportunities for India. Trans R Soc Trop Med Hyg. 2016 Mar;110(3):158-60. [PubMed] [Google Scholar]
Gupta PK. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19? Cell Immunol.
Oct;356:104187. [PubMed] [Google Scholar]
Gonzalez-Perez M, Sanchez-Tarjuelo R, Shor B, Nistal-Villan E, Ochando J. The BCG Vaccine for COVID-19:
First Verdict and Future Directions. Front Immunol. 2021;12:632478. [PubMed] [Google Scholar]